Key enzyme discovered in breast cancer proliferation and treatment resistance

12:00 EDT 12 Mar 2019 | ecancermedicalscience

Basal-like breast cancer is the most aggressive and difficult-to-treat subtype of breast cancer, and it largely overlaps with the triple-negative classification of the disease. Patients are in dire need of improved therapies that attack the underlying...

More From BioPortfolio on "Key enzyme discovered in breast cancer proliferation and treatment resistance"